Wednesday, 18 July 2018
Latest news
Main » Allergan plc (NYSE:AGN) Jumps 1.47% in Early Trade

Allergan plc (NYSE:AGN) Jumps 1.47% in Early Trade

09 May 2017

Chartist Ca invested 0% in Allergan plc Ordinary Shares (NYSE:AGN). The fund owned 6,720 shares of the company's stock after selling 951 shares during the period.

The volatility (week) for Allergan plc is at 1.10% and the volatility (month) is at 1.14%. It also upped Templeton Global Incm Fd (GIM) stake by 593,038 shares and now owns 1.91M shares.

The company is expected to report earnings of $3.31 a share for the next quarter. LLC bought a new stake in Allergan plc during the fourth quarter worth about $136,000.

More news: Powerful storm front that killed 16 threatens eastern United States

Allergan plc stated a price of 240.75 today, indicating a positive change of -1.71%. Citizens Financial Group Inc RI now owns 601 shares of the company's stock worth $138,000 after buying an additional 344 shares in the last quarter. Presently Allergan plc. (AGN) received consensus rating of " Buy " from analysts, according to FactSet data. Over the last week of the month, it was -1.34%, 3.50% over the last quarter, and 28.50% for the past six months. Sunbelt Securities Inc. purchased a new stake in Allergan plc during the fourth quarter worth approximately $107,000. Neville Rodie & Shaw Inc. now owns 15,509 shares of the company's stock valued at $3,571,000 after buying an additional 170 shares during the last quarter. First Interstate Bank raised its stake in Allergan plc by 1,731.4% in the fourth quarter.

Allergan plc (NYSE:AGN) last issued its earnings results on Wednesday, February 8th. The average volume stands around 2.7 million shares. The stock has a 50 day moving average of $239.12 and a 200-day moving average of $222.24. Allergan plc (NYSE:AGN) shares have been recently spotted -7.13% away from the 52-week high, and 31.52% away from the 52-week low mark. The stock has earnings growth of 16.20% yoy and showed a high EPS growth of 34.80% over the past five years.

Allergan plc (AGN) now has a Return on Assets (ROA) value of 10.9 Percent. The firm earned $3.86 billion during the quarter, compared to the consensus estimate of $3.77 billion.

More news: Another Top Fox News Executive Is Heading For The Exits

Amortization expenses from continuing operations was US$1.74 billion, compared with US$1.59 billion in the year-ago quarter. On average, analysts anticipate that Allergan plc will post $16.05 earnings per share for the current year. Stockholders of record on Thursday, May 18th will be paid a $0.70 dividend.

Among 4 analysts covering Anglogold Ashanti Limited (NYSE:AU), 2 have Buy rating, 1 Sell and 1 Hold.

ILLEGAL ACTIVITY WARNING: "Baldwin Brothers Inc". If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and global copyright laws. The legal version of this story can be accessed at By reviewing stock prices from the stock market history of the company and examining its analysts ratings can give an investment picture with updated information of stock which helps investors to make investing decision. With 2.73 million avg volume, 4 days are for Allergan Plc (NYSE:AGN)'s short sellers to cover AGN's short positions. Royal Bank of Canada set a $279.00 price target on Allergan plc and gave the company a buy rating in a report on Tuesday, February 14th. Mizuho reiterated a "buy" rating and set a $275.00 target price (up from $273.00) on shares of Allergan plc in a research note on Tuesday, February 7th. The stock has a consensus rating of "Buy" and an average price target of $266.15. The stock was sold at an average price of $246.68, for a total value of $17,267,600.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

More news: Manchester United injury problems ease on eve of clash with Celta Vigo

Allergan plc (NYSE:AGN) Jumps 1.47% in Early Trade